134 related articles for article (PubMed ID: 7696102)
21. Efficacy of cyclophosphamide in steroid-sensitive childhood nephrotic syndrome with different morphological lesions.
Tejani A; Phadke K; Nicastri A; Adamson O; Chen CK; Trachtman H; Tejani C
Nephron; 1985; 41(2):170-3. PubMed ID: 4047274
[TBL] [Abstract][Full Text] [Related]
22. Beneficial effect of chlorambucil in steroid-dependent and cyclophosphamide-resistant minimal change nephrotic syndrome.
Ueda N; Takahashi K; Akioka Y; Morooka M; Ogawa A; Tsuzuki K
J Nephrol; 2009; 22(5):610-5. PubMed ID: 19809993
[TBL] [Abstract][Full Text] [Related]
23. Impact of the cyclosporine-ketoconazole interaction in children with steroid-dependent idiopathic nephrotic syndrome.
El-Husseini A; El-Basuony F; Mahmoud I; Donia A; Sheashaa H; Sabry A; Hassan N; Sayed-Ahmad N; Sobh M
Eur J Clin Pharmacol; 2006 Jan; 62(1):3-8. PubMed ID: 16374637
[TBL] [Abstract][Full Text] [Related]
24. Cut-off values determined for vertebral fracture by peripheral quantitative computed tomography in Japanese women.
Gorai I; Nonaka K; Kishimoto H; Sakata H; Fujii Y; Fujita T
Osteoporos Int; 2001; 12(9):741-8. PubMed ID: 11605740
[TBL] [Abstract][Full Text] [Related]
25. Markers of bone metabolism in children with nephrotic syndrome treated with corticosteroids.
Pańczyk-Tomaszewska M; Adamczuk D; Kisiel A; Skrzypczyk P; Przedlacki J; Górska E; Stelmaszczyk-Emmel A; Demkow U; Roszkowska-Blaim M
Adv Exp Med Biol; 2015; 840():21-8. PubMed ID: 25310960
[TBL] [Abstract][Full Text] [Related]
26. Effect of glucocorticoids on growth and bone mineral density in children with nephrotic syndrome.
Ribeiro D; Zawadynski S; Pittet LF; Chevalley T; Girardin E; Parvex P
Eur J Pediatr; 2015 Jul; 174(7):911-7. PubMed ID: 25573461
[TBL] [Abstract][Full Text] [Related]
27. Longitudinal follow-up of bone mineral density in children with nephrotic syndrome and the role of calcium and vitamin D supplements.
Gulati S; Sharma RK; Gulati K; Singh U; Srivastava A
Nephrol Dial Transplant; 2005 Aug; 20(8):1598-603. PubMed ID: 15956073
[TBL] [Abstract][Full Text] [Related]
28. Bone mineral density in children and adolescents with juvenile diabetes: selective measurement of bone mineral density of trabecular and cortical bone using peripheral quantitative computed tomography.
Lettgen B; Hauffa B; Möhlmann C; Jeken C; Reiners C
Horm Res; 1995; 43(5):173-5. PubMed ID: 7782045
[TBL] [Abstract][Full Text] [Related]
29. Prophylactic calcium and vitamin D treatments in steroid-treated children with nephrotic syndrome.
Bak M; Serdaroglu E; Guclu R
Pediatr Nephrol; 2006 Mar; 21(3):350-4. PubMed ID: 16382319
[TBL] [Abstract][Full Text] [Related]
30. Long-term follow-up in children with steroid-resistant nephrotic syndrome.
Besbas N; Topaloglu R; Saatci O; Bakkaloglu A
Clin Pediatr (Phila); 1992 May; 31(5):283-8. PubMed ID: 1582094
[TBL] [Abstract][Full Text] [Related]
31. Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial.
Ponticelli C; Edefonti A; Ghio L; Rizzoni G; Rinaldi S; Gusmano R; Lama G; Zacchello G; Confalonieri R; Altieri P
Nephrol Dial Transplant; 1993; 8(12):1326-32. PubMed ID: 8159300
[TBL] [Abstract][Full Text] [Related]
32. Vertebral fracture and cortical bone changes in corticosteroid-induced osteoporosis.
Tsugeno H; Tsugeno H; Fujita T; Goto B; Sugishita T; Hosaki Y; Ashida K; Mitsunobu F; Tanizaki Y; Shiratori Y
Osteoporos Int; 2002 Aug; 13(8):650-6. PubMed ID: 12181624
[TBL] [Abstract][Full Text] [Related]
33. Bone density measurements by computed tomography in osteogenesis imperfecta type I.
Miller ME; Hangartner TN
Osteoporos Int; 1999; 9(5):427-32. PubMed ID: 10550462
[TBL] [Abstract][Full Text] [Related]
34. Treatment course of steroid-dependent nephrotic syndrome: emphasized on treatment effect.
Chen SY; Wu CY; Tsai IJ; Tsau YK
Nephrology (Carlton); 2010 Apr; 15(3):336-9. PubMed ID: 20470303
[TBL] [Abstract][Full Text] [Related]
35. Multi-drug resistance-1 gene polymorphisms in nephrotic syndrome: impact on susceptibility and response to steroids.
Youssef DM; Attia TA; El-Shal AS; Abduelometty FA
Gene; 2013 Nov; 530(2):201-7. PubMed ID: 23994685
[TBL] [Abstract][Full Text] [Related]
36. Pulse cyclophosphamide therapy in frequently relapsing nephrotic syndrome.
Gulati S; Pokhariyal S; Sharma RK; Elhence R; Kher V; Pandey CM; Gupta A
Nephrol Dial Transplant; 2001 Oct; 16(10):2013-7. PubMed ID: 11572890
[TBL] [Abstract][Full Text] [Related]
37. Decreased trabecular bone mineral density in patients with phenylketonuria measured by peripheral quantitative computed tomography.
Schwahn B; Mokov E; Scheidhauer K; Lettgen B; Schönau E
Acta Paediatr; 1998 Jan; 87(1):61-3. PubMed ID: 9510449
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of one year of growth hormone therapy in steroid-dependent nephrotic syndrome.
Loke KY; Yap HK; Zhou X; Tan SP; Chao SM; Lee KO
J Pediatr; 1997 May; 130(5):793-9. PubMed ID: 9152290
[TBL] [Abstract][Full Text] [Related]
39. Bone density measurements in pediatric patients with renal osteodystrophy.
Lima EM; Goodman WG; Kuizon BD; Gales B; Emerick A; Goldin J; Salusky IB
Pediatr Nephrol; 2003 Jun; 18(6):554-9. PubMed ID: 12712376
[TBL] [Abstract][Full Text] [Related]
40. Steroid-sensitive nephrotic syndrome: an evidence-based update of immunosuppressive treatment in children.
Larkins N; Kim S; Craig J; Hodson E
Arch Dis Child; 2016 Apr; 101(4):404-8. PubMed ID: 26289063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
